Search

Susan Nmn Ungar

Examiner (ID: 13594)

Most Active Art Unit
1642
Art Unit(s)
2899, 1642, 1806
Total Applications
662
Issued Applications
234
Pending Applications
203
Abandoned Applications
225

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4088489 [patent_doc_number] => 06025481 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Isolated nucleic acid molecules which encode human anti-Lewis b antibodies' [patent_app_type] => 1 [patent_app_number] => 9/080554 [patent_app_country] => US [patent_app_date] => 1998-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8898 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025481.pdf [firstpage_image] =>[orig_patent_app_number] => 080554 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/080554
Isolated nucleic acid molecules which encode human anti-Lewis b antibodies May 17, 1998 Issued
09/080027 INHIBITION OF ANGIOGENESIS May 14, 1998 Abandoned
Array ( [id] => 1479470 [patent_doc_number] => 06451979 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Methods of treatment using NBS-1, antibodies and proteins thereto, and uses of the antibodies' [patent_app_type] => B1 [patent_app_number] => 09/081975 [patent_app_country] => US [patent_app_date] => 1998-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 39 [patent_no_of_words] => 14565 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451979.pdf [firstpage_image] =>[orig_patent_app_number] => 09081975 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/081975
Methods of treatment using NBS-1, antibodies and proteins thereto, and uses of the antibodies May 11, 1998 Issued
09/069725 PROTEINS ASSOCIATED WITH EGF SIGNALING Apr 28, 1998 Abandoned
Array ( [id] => 4173388 [patent_doc_number] => 06140470 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Human monoclonal anti-tumor antibodies' [patent_app_type] => 1 [patent_app_number] => 8/983607 [patent_app_country] => US [patent_app_date] => 1998-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20347 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140470.pdf [firstpage_image] =>[orig_patent_app_number] => 983607 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/983607
Human monoclonal anti-tumor antibodies Apr 26, 1998 Issued
Array ( [id] => 4406739 [patent_doc_number] => 06309816 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Methods for diagnosing cancer by measuring creatine kinase' [patent_app_type] => 1 [patent_app_number] => 9/060703 [patent_app_country] => US [patent_app_date] => 1998-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2227 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/309/06309816.pdf [firstpage_image] =>[orig_patent_app_number] => 060703 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/060703
Methods for diagnosing cancer by measuring creatine kinase Apr 14, 1998 Issued
Array ( [id] => 4411577 [patent_doc_number] => 06300476 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Anti-peptide antibody against human cytochrome P450 3A4' [patent_app_type] => 1 [patent_app_number] => 9/057897 [patent_app_country] => US [patent_app_date] => 1998-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 11233 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300476.pdf [firstpage_image] =>[orig_patent_app_number] => 057897 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/057897
Anti-peptide antibody against human cytochrome P450 3A4 Apr 8, 1998 Issued
Array ( [id] => 4158686 [patent_doc_number] => 06103873 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Isolated renal cancer specific antigen' [patent_app_type] => 1 [patent_app_number] => 9/053453 [patent_app_country] => US [patent_app_date] => 1998-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7362 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103873.pdf [firstpage_image] =>[orig_patent_app_number] => 053453 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/053453
Isolated renal cancer specific antigen Mar 31, 1998 Issued
Array ( [id] => 4307352 [patent_doc_number] => 06241985 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Method and composition for reconforming multi-epitopic antigens to initiate an immune response' [patent_app_type] => 1 [patent_app_number] => 8/913290 [patent_app_country] => US [patent_app_date] => 1998-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10724 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/241/06241985.pdf [firstpage_image] =>[orig_patent_app_number] => 913290 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/913290
Method and composition for reconforming multi-epitopic antigens to initiate an immune response Mar 19, 1998 Issued
Array ( [id] => 4186676 [patent_doc_number] => 06150508 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen' [patent_app_type] => 1 [patent_app_number] => 9/044668 [patent_app_country] => US [patent_app_date] => 1998-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 24 [patent_no_of_words] => 17430 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150508.pdf [firstpage_image] =>[orig_patent_app_number] => 044668 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/044668
Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen Mar 17, 1998 Issued
Array ( [id] => 876847 [patent_doc_number] => 07358347 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-04-15 [patent_title] => 'MEN1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/380337 [patent_app_country] => US [patent_app_date] => 1998-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22062 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358347.pdf [firstpage_image] =>[orig_patent_app_number] => 09380337 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/380337
MEN1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides and uses thereof Mar 3, 1998 Issued
09/032369 CHIMERIC CELL-SURFACE RECEPTORS THAT UNDERGO ANTIGEN-INDUCED ASSOCIATION Feb 26, 1998 Abandoned
09/030298 NOVEL MULTITARGET DRUGS AND THERAPEUTIC APPLICATIONS Feb 24, 1998 Abandoned
09/030579 HUMAN C-MAF COMPOSITIONS AND METHODS OF USE THEREOF Feb 23, 1998 Abandoned
Array ( [id] => 4306811 [patent_doc_number] => 06326464 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'P53 protein variants and therapeutic uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/983035 [patent_app_country] => US [patent_app_date] => 1998-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 33199 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326464.pdf [firstpage_image] =>[orig_patent_app_number] => 983035 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/983035
P53 protein variants and therapeutic uses thereof Feb 19, 1998 Issued
Array ( [id] => 4330494 [patent_doc_number] => 06320022 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Adrenomedullin peptides' [patent_app_type] => 1 [patent_app_number] => 9/011922 [patent_app_country] => US [patent_app_date] => 1998-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 76 [patent_no_of_words] => 21519 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/320/06320022.pdf [firstpage_image] =>[orig_patent_app_number] => 011922 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/011922
Adrenomedullin peptides Feb 16, 1998 Issued
09/025012 HAPTEN-MODIFIED TUMOR CELL MEMBRANES AND METHODS OF MAKING AND USING HAPTEN-MODIFIED TUMOR CELL MEMBRANES Feb 16, 1998 Abandoned
08/973603 HAPTEN MODIFIED TUMOR CELL EXTRACT AND METHODS OF TREATING OR SCREENING FOR CANCER Feb 12, 1998 Abandoned
Array ( [id] => 4141228 [patent_doc_number] => 06063379 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Anti-idiotypic monoclonal antibodies and compositions including the anti-idiotypic monoclonal antibodies' [patent_app_type] => 1 [patent_app_number] => 9/015540 [patent_app_country] => US [patent_app_date] => 1998-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4865 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063379.pdf [firstpage_image] =>[orig_patent_app_number] => 015540 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/015540
Anti-idiotypic monoclonal antibodies and compositions including the anti-idiotypic monoclonal antibodies Jan 28, 1998 Issued
Array ( [id] => 4146234 [patent_doc_number] => 06138680 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Method for destroying retinal pigment epithelial cells' [patent_app_type] => 1 [patent_app_number] => 9/014492 [patent_app_country] => US [patent_app_date] => 1998-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2992 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/138/06138680.pdf [firstpage_image] =>[orig_patent_app_number] => 014492 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/014492
Method for destroying retinal pigment epithelial cells Jan 27, 1998 Issued
Menu